Home
News
Press Releases and Articles
Calendar of Events
How to Help
Gates Foundation Grant to GAELF
The Global Alliance
Global Alliance History
Goals
Global Alliance Structure
Executive Group
Partnerships
GAELF Logo
LF Webring
About LF
What is LF?
How is LF Contracted?
How is LF Diagnosed?
Prevent/Eliminate LF
Manage LF
LF and Children
Additional Treatment Benefits
LF Slideshow
In Depth Disease Info
Where is LF?
Countries and Map List
Moving Forward
Starting Out
Success Stories
Progress and Plans
Elimination Strategy
Operational Research
Progress to Date
Economics of LF
Return on Investment
The Way Ahead
Highlighted Programmes
   Burkina Faso
   Sri Lanka

For the Media
Press Release Archive
Press Kits
Photos
Articles
Video Clips
Media Contacts
FAQs
Publications
LF News
Annual Reports
General Publications
Training Material
Videos
Journal Articles & Other Pubs
EG Updates
Gates Foundation

Senegal
   

The goal of the National Programme to Eliminate Lymphatic Filariasis (NPELF) is to eliminate LF by 2017

The World Health Organization (WHO) is the Secretariat of the Global Programme to Eliminate Lymphatic Filariasis and provides technical and financial support. Detailed information (endemicity, MDA, monitoring and evaluation) on this and other NPELF can be found on www.who.int/lymphatic_filariais.

   

Implementation of the NPELF

map


MDA Treatments

 

Data not available


Country data

Population

11,900,000 (2006)

Endemicity

5,100,000 at risk in 31 out of 65 implementation units

Clinical manifestations

 

Drug regime

Albendazole – donated by GlaxoSmithKline
Mectizan® - donated by Merck & Co. Inc.

MDA implementation cycle

The first MDA is planned for late 2007 in 7 districts in Tamabacounda. The target population is approximately 550,000

Treatment strategy

Door-to-door and by groups in village and district public places

Social mobilisation

National and community radio and television. The population will be sensitised through talks and the production of edcuational material (posters, folders etc) in the districts

Vector control

None. It is planned to integrate with the Malaria Control Programme

Co-implementation

Onchocerciasis, schistosomiasis, soil-transmitted helminths, trachoma - integration developing

Recognition

Filaria species

 

Wuchereria bancrofti

tick

Onchocerca volvulus

tick

Loa loa

 

Mansonella perstans

 

Vectors

 

Anopheles gambiae complex
tick
Simulium damnosum sl tick Culex quinquefasciatus   Culicoides spp.  

An. funestus

 

S. naevis

 

 

 

 

 

Diagnostics

 

ICT tick Blood slide   Skin snips   Blood smears; Mazotti reaction  

Night blood smears

 

REMO

 

Skin biopsies

 

Counting Chamber

 

Capacity Building
The Senegalese programme was established in 2007. People who are targeted are members of the 7 medical district management teams (4 per medical district), and the 32 members of the Tambacounda medical area management team. In addition training of approximately 100 chief station nurses of these medical districts is planned.

The chief station nurses will train approximately 1,450 community drug distributors prior to the 2007 mass distribution campaign.

Programme Support & Partnerships
The NPELF is included in both the national and district (IU) level budgets

Partners

Activities

Mapping

MDA

Social Mobilisation

Morbidity Management

Hydrocoele Surgery

Operational Research

Training

M&E Surveillance

Funding partners

World Health Organization
tick
         
tick
tick
 

Mectizan Donation Program

 

tick

 

 

 

 

 

 

 

Disability prevention programme
No programme

Budget line
The Ministry of Health has a budget line for 2007

 

© Global Alliance to Eliminate Lymphatic Filariasis